Tag: Cancer: Leukemia
Allogeneic HCT After Primary Induction Failure Beneficial in Leukemia
Overall survival rates were 29.8 and 21.6 percent five and 10 years after hematopoietic stem cell transplant
Peripheral Blood Haplo-SCT Feasible for Leukemia Patients 70 Years and Older
Haploidentical stem cell transplantation using nonmyeloablative conditioning regimen effective in highly selected patients
Air Pollution May Increase Risk for Childhood Leukemia
Strongest association seen for benzene exposure and acute myeloid leukemia
ASH: MRD-Directed Ibrutinib-Venetoclax Treatment Beneficial in Leukemia
Improvement in survival seen with measurable residual disease-directed ibrutinib-venetoclax versus fludarabine-cyclophosphamide-rituximab
Poor Physical Function Persists in Childhood Cancer Survivors
Findings seen for patients diagnosed with acute lymphoblastic leukemia and non-Hodgkin lymphoma from the 1970s through the 1990s
Fewer Complications Seen With Vitamin C, D Supplementation in AML
Overall survival did not differ, but significant interaction found between supplementation and NPM1 with survival
Risks for MDS/Leukemia Increased for Survivors of Common Lymphoid Neoplasms
Risks for therapy-related myelodysplastic syndrome/acute myeloid leukemia elevated, but risks lower in recent years
Misdiagnosis Common for Suspected Myelodysplastic Neoplasms
About one-third of cases were reclassified following central review; receipt of inappropriate meds reported in 7 percent of misdiagnosed cases
Leukemia With IKZF₁ Deletion Benefits From Prolonged Maintenance Therapy
Prolonged maintenance therapy for IKZF₁del improved five-year cumulative risk for relapse and event-free survival
Spleen Volume Linked to Outcome After HSCT for Leukemia Patients
Higher spleen volume tied to inferior overall survival and increased incidence of nonrelapse mortality for patients with AML undergoing hematopoietic stem cell transplant
